As reported in The Economic Times, AstraZeneca, an Anglo-Swedish drug company and the world’s No.7 pharmaceutical company, seems to be following GlaxoSmithKline and Sanofi-Aventis in seeking tie-ups with generic drug makers. With an intention to brand and market the generic drugs in many of its emerging markets where it has strong commercial footprint, AstraZeneca has entered into a Licence and Supply Agreement with India’s Ahmedabad-based Torrent Pharmaceuticals Ltd. for product licensing. AstraZeneca made this formal announcement on 11th March 2010.

The crux of the agreement is that Torrent will supply to AstraZeneca a portfolio of generic medicines for which Torrent [...]

OUVRIR MON COMPTE CREATE MY ACCOUNT

  Un problème avec cet article ? / A problem with this article?